Global Oral Hypoglycemic Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 101

Published Date: 04 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The drugs can treat diabetic by reducing glucose concentrations.

According to our (Global Info Research) latest study, the global Oral Hypoglycemic Agents market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The drugs can treat diabete by reducing glucose concentrations. These drugs mainly focus on the Type 2 diabetes. Oral drugs can control the glucose by stimulating the islet cells.

This report is a detailed and comprehensive analysis for global Oral Hypoglycemic Agents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Oral Hypoglycemic Agents market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oral Hypoglycemic Agents market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oral Hypoglycemic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oral Hypoglycemic Agents market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Hypoglycemic Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Hypoglycemic Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly and Company, Janssen Pharmaceuticals, Astellas Pharma Inc., AstraZeneca plc and Sanofi S.A., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Oral Hypoglycemic Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Liquid
Capsule
Tablet

Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
Eli Lilly and Company
Janssen Pharmaceuticals
Astellas Pharma Inc.
AstraZeneca plc
Sanofi S.A.
Takeda
Pfizer Inc
Beohringer Ingelgeim
Merk and Co.
Bristol Myers Squibb
Novartis International AG
Abbott Laboratories
Biocon Limited

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Hypoglycemic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Hypoglycemic Agents, with revenue, gross margin and global market share of Oral Hypoglycemic Agents from 2018 to 2023.
Chapter 3, the Oral Hypoglycemic Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oral Hypoglycemic Agents market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Hypoglycemic Agents.
Chapter 13, to describe Oral Hypoglycemic Agents research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oral Hypoglycemic Agents
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Oral Hypoglycemic Agents by Type
        1.3.1 Overview: Global Oral Hypoglycemic Agents Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Oral Hypoglycemic Agents Consumption Value Market Share by Type in 2022
        1.3.3 Liquid
        1.3.4 Capsule
        1.3.5 Tablet
    1.4 Global Oral Hypoglycemic Agents Market by Application
        1.4.1 Overview: Global Oral Hypoglycemic Agents Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
    1.5 Global Oral Hypoglycemic Agents Market Size & Forecast
    1.6 Global Oral Hypoglycemic Agents Market Size and Forecast by Region
        1.6.1 Global Oral Hypoglycemic Agents Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Oral Hypoglycemic Agents Market Size by Region, (2018-2029)
        1.6.3 North America Oral Hypoglycemic Agents Market Size and Prospect (2018-2029)
        1.6.4 Europe Oral Hypoglycemic Agents Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Oral Hypoglycemic Agents Market Size and Prospect (2018-2029)
        1.6.6 South America Oral Hypoglycemic Agents Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Oral Hypoglycemic Agents Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Eli Lilly and Company
        2.1.1 Eli Lilly and Company Details
        2.1.2 Eli Lilly and Company Major Business
        2.1.3 Eli Lilly and Company Oral Hypoglycemic Agents Product and Solutions
        2.1.4 Eli Lilly and Company Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Eli Lilly and Company Recent Developments and Future Plans
    2.2 Janssen Pharmaceuticals
        2.2.1 Janssen Pharmaceuticals Details
        2.2.2 Janssen Pharmaceuticals Major Business
        2.2.3 Janssen Pharmaceuticals Oral Hypoglycemic Agents Product and Solutions
        2.2.4 Janssen Pharmaceuticals Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Janssen Pharmaceuticals Recent Developments and Future Plans
    2.3 Astellas Pharma Inc.
        2.3.1 Astellas Pharma Inc. Details
        2.3.2 Astellas Pharma Inc. Major Business
        2.3.3 Astellas Pharma Inc. Oral Hypoglycemic Agents Product and Solutions
        2.3.4 Astellas Pharma Inc. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Astellas Pharma Inc. Recent Developments and Future Plans
    2.4 AstraZeneca plc
        2.4.1 AstraZeneca plc Details
        2.4.2 AstraZeneca plc Major Business
        2.4.3 AstraZeneca plc Oral Hypoglycemic Agents Product and Solutions
        2.4.4 AstraZeneca plc Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 AstraZeneca plc Recent Developments and Future Plans
    2.5 Sanofi S.A.
        2.5.1 Sanofi S.A. Details
        2.5.2 Sanofi S.A. Major Business
        2.5.3 Sanofi S.A. Oral Hypoglycemic Agents Product and Solutions
        2.5.4 Sanofi S.A. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Sanofi S.A. Recent Developments and Future Plans
    2.6 Takeda
        2.6.1 Takeda Details
        2.6.2 Takeda Major Business
        2.6.3 Takeda Oral Hypoglycemic Agents Product and Solutions
        2.6.4 Takeda Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Takeda Recent Developments and Future Plans
    2.7 Pfizer Inc
        2.7.1 Pfizer Inc Details
        2.7.2 Pfizer Inc Major Business
        2.7.3 Pfizer Inc Oral Hypoglycemic Agents Product and Solutions
        2.7.4 Pfizer Inc Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Pfizer Inc Recent Developments and Future Plans
    2.8 Beohringer Ingelgeim
        2.8.1 Beohringer Ingelgeim Details
        2.8.2 Beohringer Ingelgeim Major Business
        2.8.3 Beohringer Ingelgeim Oral Hypoglycemic Agents Product and Solutions
        2.8.4 Beohringer Ingelgeim Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Beohringer Ingelgeim Recent Developments and Future Plans
    2.9 Merk and Co.
        2.9.1 Merk and Co. Details
        2.9.2 Merk and Co. Major Business
        2.9.3 Merk and Co. Oral Hypoglycemic Agents Product and Solutions
        2.9.4 Merk and Co. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Merk and Co. Recent Developments and Future Plans
    2.10 Bristol Myers Squibb
        2.10.1 Bristol Myers Squibb Details
        2.10.2 Bristol Myers Squibb Major Business
        2.10.3 Bristol Myers Squibb Oral Hypoglycemic Agents Product and Solutions
        2.10.4 Bristol Myers Squibb Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Bristol Myers Squibb Recent Developments and Future Plans
    2.11 Novartis International AG
        2.11.1 Novartis International AG Details
        2.11.2 Novartis International AG Major Business
        2.11.3 Novartis International AG Oral Hypoglycemic Agents Product and Solutions
        2.11.4 Novartis International AG Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Novartis International AG Recent Developments and Future Plans
    2.12 Abbott Laboratories
        2.12.1 Abbott Laboratories Details
        2.12.2 Abbott Laboratories Major Business
        2.12.3 Abbott Laboratories Oral Hypoglycemic Agents Product and Solutions
        2.12.4 Abbott Laboratories Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Abbott Laboratories Recent Developments and Future Plans
    2.13 Biocon Limited
        2.13.1 Biocon Limited Details
        2.13.2 Biocon Limited Major Business
        2.13.3 Biocon Limited Oral Hypoglycemic Agents Product and Solutions
        2.13.4 Biocon Limited Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Biocon Limited Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Oral Hypoglycemic Agents Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Oral Hypoglycemic Agents by Company Revenue
        3.2.2 Top 3 Oral Hypoglycemic Agents Players Market Share in 2022
        3.2.3 Top 6 Oral Hypoglycemic Agents Players Market Share in 2022
    3.3 Oral Hypoglycemic Agents Market: Overall Company Footprint Analysis
        3.3.1 Oral Hypoglycemic Agents Market: Region Footprint
        3.3.2 Oral Hypoglycemic Agents Market: Company Product Type Footprint
        3.3.3 Oral Hypoglycemic Agents Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Oral Hypoglycemic Agents Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Oral Hypoglycemic Agents Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Oral Hypoglycemic Agents Consumption Value Market Share by Application (2018-2023)
    5.2 Global Oral Hypoglycemic Agents Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Oral Hypoglycemic Agents Consumption Value by Type (2018-2029)
    6.2 North America Oral Hypoglycemic Agents Consumption Value by Application (2018-2029)
    6.3 North America Oral Hypoglycemic Agents Market Size by Country
        6.3.1 North America Oral Hypoglycemic Agents Consumption Value by Country (2018-2029)
        6.3.2 United States Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        6.3.3 Canada Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        6.3.4 Mexico Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Oral Hypoglycemic Agents Consumption Value by Type (2018-2029)
    7.2 Europe Oral Hypoglycemic Agents Consumption Value by Application (2018-2029)
    7.3 Europe Oral Hypoglycemic Agents Market Size by Country
        7.3.1 Europe Oral Hypoglycemic Agents Consumption Value by Country (2018-2029)
        7.3.2 Germany Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        7.3.3 France Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        7.3.5 Russia Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        7.3.6 Italy Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Oral Hypoglycemic Agents Market Size by Region
        8.3.1 Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Region (2018-2029)
        8.3.2 China Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        8.3.3 Japan Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        8.3.4 South Korea Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        8.3.5 India Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        8.3.7 Australia Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Oral Hypoglycemic Agents Consumption Value by Type (2018-2029)
    9.2 South America Oral Hypoglycemic Agents Consumption Value by Application (2018-2029)
    9.3 South America Oral Hypoglycemic Agents Market Size by Country
        9.3.1 South America Oral Hypoglycemic Agents Consumption Value by Country (2018-2029)
        9.3.2 Brazil Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        9.3.3 Argentina Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Oral Hypoglycemic Agents Market Size by Country
        10.3.1 Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Country (2018-2029)
        10.3.2 Turkey Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)
        10.3.4 UAE Oral Hypoglycemic Agents Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Oral Hypoglycemic Agents Market Drivers
    11.2 Oral Hypoglycemic Agents Market Restraints
    11.3 Oral Hypoglycemic Agents Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Oral Hypoglycemic Agents Industry Chain
    12.2 Oral Hypoglycemic Agents Upstream Analysis
    12.3 Oral Hypoglycemic Agents Midstream Analysis
    12.4 Oral Hypoglycemic Agents Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Hypoglycemic Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Oral Hypoglycemic Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Oral Hypoglycemic Agents Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Oral Hypoglycemic Agents Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Eli Lilly and Company Company Information, Head Office, and Major Competitors
    Table 6. Eli Lilly and Company Major Business
    Table 7. Eli Lilly and Company Oral Hypoglycemic Agents Product and Solutions
    Table 8. Eli Lilly and Company Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Eli Lilly and Company Recent Developments and Future Plans
    Table 10. Janssen Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 11. Janssen Pharmaceuticals Major Business
    Table 12. Janssen Pharmaceuticals Oral Hypoglycemic Agents Product and Solutions
    Table 13. Janssen Pharmaceuticals Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Janssen Pharmaceuticals Recent Developments and Future Plans
    Table 15. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
    Table 16. Astellas Pharma Inc. Major Business
    Table 17. Astellas Pharma Inc. Oral Hypoglycemic Agents Product and Solutions
    Table 18. Astellas Pharma Inc. Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Astellas Pharma Inc. Recent Developments and Future Plans
    Table 20. AstraZeneca plc Company Information, Head Office, and Major Competitors
    Table 21. AstraZeneca plc Major Business
    Table 22. AstraZeneca plc Oral Hypoglycemic Agents Product and Solutions
    Table 23. AstraZeneca plc Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. AstraZeneca plc Recent Developments and Future Plans
    Table 25. Sanofi S.A. Company Information, Head Office, and Major Competitors
    Table 26. Sanofi S.A. Major Business
    Table 27. Sanofi S.A. Oral Hypoglycemic Agents Product and Solutions
    Table 28. Sanofi S.A. Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Sanofi S.A. Recent Developments and Future Plans
    Table 30. Takeda Company Information, Head Office, and Major Competitors
    Table 31. Takeda Major Business
    Table 32. Takeda Oral Hypoglycemic Agents Product and Solutions
    Table 33. Takeda Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Takeda Recent Developments and Future Plans
    Table 35. Pfizer Inc Company Information, Head Office, and Major Competitors
    Table 36. Pfizer Inc Major Business
    Table 37. Pfizer Inc Oral Hypoglycemic Agents Product and Solutions
    Table 38. Pfizer Inc Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Pfizer Inc Recent Developments and Future Plans
    Table 40. Beohringer Ingelgeim Company Information, Head Office, and Major Competitors
    Table 41. Beohringer Ingelgeim Major Business
    Table 42. Beohringer Ingelgeim Oral Hypoglycemic Agents Product and Solutions
    Table 43. Beohringer Ingelgeim Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Beohringer Ingelgeim Recent Developments and Future Plans
    Table 45. Merk and Co. Company Information, Head Office, and Major Competitors
    Table 46. Merk and Co. Major Business
    Table 47. Merk and Co. Oral Hypoglycemic Agents Product and Solutions
    Table 48. Merk and Co. Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Merk and Co. Recent Developments and Future Plans
    Table 50. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
    Table 51. Bristol Myers Squibb Major Business
    Table 52. Bristol Myers Squibb Oral Hypoglycemic Agents Product and Solutions
    Table 53. Bristol Myers Squibb Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Bristol Myers Squibb Recent Developments and Future Plans
    Table 55. Novartis International AG Company Information, Head Office, and Major Competitors
    Table 56. Novartis International AG Major Business
    Table 57. Novartis International AG Oral Hypoglycemic Agents Product and Solutions
    Table 58. Novartis International AG Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Novartis International AG Recent Developments and Future Plans
    Table 60. Abbott Laboratories Company Information, Head Office, and Major Competitors
    Table 61. Abbott Laboratories Major Business
    Table 62. Abbott Laboratories Oral Hypoglycemic Agents Product and Solutions
    Table 63. Abbott Laboratories Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Abbott Laboratories Recent Developments and Future Plans
    Table 65. Biocon Limited Company Information, Head Office, and Major Competitors
    Table 66. Biocon Limited Major Business
    Table 67. Biocon Limited Oral Hypoglycemic Agents Product and Solutions
    Table 68. Biocon Limited Oral Hypoglycemic Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Biocon Limited Recent Developments and Future Plans
    Table 70. Global Oral Hypoglycemic Agents Revenue (USD Million) by Players (2018-2023)
    Table 71. Global Oral Hypoglycemic Agents Revenue Share by Players (2018-2023)
    Table 72. Breakdown of Oral Hypoglycemic Agents by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Oral Hypoglycemic Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 74. Head Office of Key Oral Hypoglycemic Agents Players
    Table 75. Oral Hypoglycemic Agents Market: Company Product Type Footprint
    Table 76. Oral Hypoglycemic Agents Market: Company Product Application Footprint
    Table 77. Oral Hypoglycemic Agents New Market Entrants and Barriers to Market Entry
    Table 78. Oral Hypoglycemic Agents Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Oral Hypoglycemic Agents Consumption Value (USD Million) by Type (2018-2023)
    Table 80. Global Oral Hypoglycemic Agents Consumption Value Share by Type (2018-2023)
    Table 81. Global Oral Hypoglycemic Agents Consumption Value Forecast by Type (2024-2029)
    Table 82. Global Oral Hypoglycemic Agents Consumption Value by Application (2018-2023)
    Table 83. Global Oral Hypoglycemic Agents Consumption Value Forecast by Application (2024-2029)
    Table 84. North America Oral Hypoglycemic Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 85. North America Oral Hypoglycemic Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 86. North America Oral Hypoglycemic Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. North America Oral Hypoglycemic Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. North America Oral Hypoglycemic Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 89. North America Oral Hypoglycemic Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 90. Europe Oral Hypoglycemic Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Europe Oral Hypoglycemic Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Europe Oral Hypoglycemic Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 93. Europe Oral Hypoglycemic Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 94. Europe Oral Hypoglycemic Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Oral Hypoglycemic Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 97. Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 98. Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 99. Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 100. Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Region (2018-2023) & (USD Million)
    Table 101. Asia-Pacific Oral Hypoglycemic Agents Consumption Value by Region (2024-2029) & (USD Million)
    Table 102. South America Oral Hypoglycemic Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 103. South America Oral Hypoglycemic Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 104. South America Oral Hypoglycemic Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 105. South America Oral Hypoglycemic Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 106. South America Oral Hypoglycemic Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. South America Oral Hypoglycemic Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 110. Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 111. Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 113. Middle East & Africa Oral Hypoglycemic Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 114. Oral Hypoglycemic Agents Raw Material
    Table 115. Key Suppliers of Oral Hypoglycemic Agents Raw Materials
List of Figures
    Figure 1. Oral Hypoglycemic Agents Picture
    Figure 2. Global Oral Hypoglycemic Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Oral Hypoglycemic Agents Consumption Value Market Share by Type in 2022
    Figure 4. Liquid
    Figure 5. Capsule
    Figure 6. Tablet
    Figure 7. Global Oral Hypoglycemic Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Oral Hypoglycemic Agents Consumption Value Market Share by Application in 2022
    Figure 9. Hospital Pharmacies Picture
    Figure 10. Retail Pharmacies Picture
    Figure 11. Online Pharmacies Picture
    Figure 12. Global Oral Hypoglycemic Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Oral Hypoglycemic Agents Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Oral Hypoglycemic Agents Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Oral Hypoglycemic Agents Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Oral Hypoglycemic Agents Consumption Value Market Share by Region in 2022
    Figure 17. North America Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Oral Hypoglycemic Agents Revenue Share by Players in 2022
    Figure 23. Oral Hypoglycemic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Oral Hypoglycemic Agents Market Share in 2022
    Figure 25. Global Top 6 Players Oral Hypoglycemic Agents Market Share in 2022
    Figure 26. Global Oral Hypoglycemic Agents Consumption Value Share by Type (2018-2023)
    Figure 27. Global Oral Hypoglycemic Agents Market Share Forecast by Type (2024-2029)
    Figure 28. Global Oral Hypoglycemic Agents Consumption Value Share by Application (2018-2023)
    Figure 29. Global Oral Hypoglycemic Agents Market Share Forecast by Application (2024-2029)
    Figure 30. North America Oral Hypoglycemic Agents Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Oral Hypoglycemic Agents Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Oral Hypoglycemic Agents Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Oral Hypoglycemic Agents Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Oral Hypoglycemic Agents Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Oral Hypoglycemic Agents Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Oral Hypoglycemic Agents Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Oral Hypoglycemic Agents Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Oral Hypoglycemic Agents Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Oral Hypoglycemic Agents Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Oral Hypoglycemic Agents Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Oral Hypoglycemic Agents Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Oral Hypoglycemic Agents Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Oral Hypoglycemic Agents Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Oral Hypoglycemic Agents Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 64. Oral Hypoglycemic Agents Market Drivers
    Figure 65. Oral Hypoglycemic Agents Market Restraints
    Figure 66. Oral Hypoglycemic Agents Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Oral Hypoglycemic Agents in 2022
    Figure 69. Manufacturing Process Analysis of Oral Hypoglycemic Agents
    Figure 70. Oral Hypoglycemic Agents Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Eli Lilly and Company
Janssen Pharmaceuticals
Astellas Pharma Inc.
AstraZeneca plc
Sanofi S.A.
Takeda
Pfizer Inc
Beohringer Ingelgeim
Merk and Co.
Bristol Myers Squibb
Novartis International AG
Abbott Laboratories
Biocon Limited

Related Reports

Global Oral Hypoglycemic Agents Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Oral Hypoglycemic Agents Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 29 Jan 2021

date Pharma & Healthcare

The Oral Hypoglycemic Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Oral Hypoglycemic Agents Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Oral Hypoglycemic Agents Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 09 Jan 2022

date Pharma & Healthcare

Global Oral Hypoglycemic Agents Supply, Demand and Key Producers, 2023-2029

Global Oral Hypoglycemic Agents Supply, Demand and Key Producers, 2023-2029

date 13 Feb 2023

date Pharma & Healthcare

The global Oral Hypoglycemic Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Oral Hypoglycemic Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Oral Hypoglycemic Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 15 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Hypoglycemic Agents market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

oral hypoglycemic agents

oral hypoglycemic agents ohas

oral hypoglycemic agents insulin analogues

oral hypoglycemic agents insulin injection

oral hypoglycemic agents insulin injection production demand producers

Oral Hypoglycemic Agents (OHAs)

Oral Hypoglycemic Agents and Insulin Analogues

Oral Hypoglycemic Agents and Insulin Injection

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>